tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Divi’s Laboratories Announces Trading Window Closure

Story Highlights
Divi’s Laboratories Announces Trading Window Closure

Elevate Your Investing Strategy:

Divi’s Laboratories Limited ( (IN:DIVISLAB) ) just unveiled an announcement.

Divi’s Laboratories Limited announced the closure of its trading window from July 1, 2025, until 48 hours after the release of its unaudited financial results for the quarter ending June 30, 2025. This move is in compliance with the company’s Code of Conduct to regulate trading by insiders and is a routine procedure aimed at ensuring transparency and preventing insider trading.

More about Divi’s Laboratories Limited

Divi’s Laboratories Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company is a significant player in the global pharmaceutical market, providing essential components for various medications.

Average Trading Volume: 19,594

Current Market Cap: 1767.5B INR

Learn more about DIVISLAB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1